Heart Disease Trial, Recruiting NCT06633159 Sponsor: The League of Clinical Research, Russia Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06633159
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 (Prospective – joining going forward):

  • People who have been recommended to have a heart procedure to fix a leaky heart valve (called mitral regurgitation) using a specific device called the MitraClip G4
  • People aged 18 years or older
  • People who understand and are willing to sign a consent form agreeing to how their personal information will be used

Group 2 (Retrospective – people who already had the procedure):

  • People who have already had the MitraClip G4 device used to fix a leaky mitral heart valve
  • People aged 18 years or older
  • People whose procedure took place on or after January 1, 2022

Who may not be able to join:

Group 1 (Prospective):

  • People whose life expectancy is estimated to be less than 12 months
  • People with other serious health conditions that would make it difficult to attend required study visits
  • People with conditions that may affect their ability to follow the study requirements, such as dementia, certain mental health conditions, or substance dependence
  • People currently taking part in another clinical trial, or who have previously participated in this specific trial

Group 2 (Retrospective):

  • People whose treating doctor is unable to access their original medical records or other required health documents to gather the necessary information for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sergey A Boytsov, Prof., Research Institute of Cardiology

Phone: +79166950530

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The League of Clinical Research, Russia
Registry
ClinicalTrials.gov
Start date
15 April 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Cardiovascular mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov